Rheumatic heart disease and socioeconomic development

Nascimento, Bruno Ramos; Beaton, Andrea

doi:10.1016/s2214-109x(19)30369-9

Cited by 7 publications

(5 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Following the trend of increasing socioeconomic conditions, cardiovascular diseases that are sensitive to socioeconomic conditions and healthcare accessibility [ 26 , 30 , 31 ], congenital heart disease and rheumatic heart disease show significant decreases [ 30 – 32 ]. It has been predicted by the evolution of cardiovascular disease where pestilence and famine, common in low socioeconomic status, will move to degenerative man-made disease [ 26 , 33 ].…”

Section: Discussionmentioning

confidence: 99%

The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study

Muharram,

Multazam,

Mustofa

et al. 2024

J Epidemiol Glob Health

View full text Add to dashboard Cite

Importance Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity. Compared with disease burden rates in 1990, significant reductions in Disability-Adjusted Life Years (DALYs) burden rates for CVD have been recorded. However, general DALYs rates have not changed in Indonesia in the past 30 years. Thus, assessing Indonesian CVD burdens will be an essential first step in determining primary disease interventions. Objective To determine the national and province-level burden of CVD from 1990 to 2019 in Indonesia. Design, Setting, and Participants A retrospective observational study was conducted using data from the Global Burden of Disease (GBD) 2019, provided by the Institute of Health Metrics and Evaluation (IHME), to analyze trends in the burden of CVD, including mortality, morbidity, and prevalence characteristics of 12 underlying CVDs. Exposures Residence in Indonesia. Main Outcomes and Measures Mortality, incidence, prevalence, death, and DALYs of CVD. Results CVD deaths have doubled from 278 million in 1990 to 651 million in 2019. All CVDs recorded increased death rates, except for rheumatic heart disease (RHD) (− 69%) and congenital heart disease (CHD) (− 37%). Based on underlying diseases, stroke and ischemic heart disease (IHD) are still the leading causes of mortality and morbidity in Indonesia, whereas stroke and peripheral artery disease (PAD) are the most prevalent CVDs. Indonesia has the second worst CVD DALYs rates compared to ASEAN countries after Laos. At provincial levels, the highest CVD DALY rates were recorded in Bangka Belitung, South Kalimantan, and Yogyakarta. In terms of DALYs rate changes, they were recorded in West Nusa Tenggara (24%), South Kalimantan (18%), and Central Java (11%). Regarding sex, only RHD, and PAD burdens were dominated by females. Conclusions CVD mortality, morbidity, and prevalence rates increased in Indonesia from 1990 to 2019, especially for stroke and ischemic heart disease. The burden is exceptionally high, even when compared to other Southeast Asian countries and the global downward trend. GBD has many limitations. However, these data could provide policymakers with a broad view of CVD conditions in Indonesia.

show abstract

Section: Discussionmentioning

confidence: 99%

The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study

Muharram,

Multazam,

Mustofa

et al. 2024

J Epidemiol Glob Health

View full text Add to dashboard Cite

show abstract

“…Most patients were male (n = 35, 67.3%), and of the indigenous Kadazan-Dusun ethnicity (n = 21, 40.4%) (Table 1). The mean age at time of presentation was 9.58 years (SD 2.6, range [3][4][5][6][7][8][9][10][11][12][13][14]. The majority of patients seen were in the West Coast (n = 24, 46.2%) and Kudat divisions of Sabah (n = 13, 25%).…”

Section: Resultsmentioning

confidence: 99%

“…The occurrence of this condition across diverse ethnic groups reflects the underlying widespread socio-economic disadvantage throughout the state. 13 The incidence of initial cases of acute rheumatic fever is highest in children aged 5-14 years 14 , with patients presenting a mean age of 9.58 years. Although it is uncommon to have patients presenting below 5 years of age, there was a 3-year-old patient who presented with severe mitral regurgitation and fulfilled the definitive criteria for acute rheumatic fever.…”

Section: Discussionmentioning

confidence: 99%

Acute rheumatic fever in the paediatric population: a descriptive study in the Malaysian state of Sabah

2021

View full text Add to dashboard Cite

Introduction: Rheumatic heart disease is among the leading causes of acquired valvular heart disease in the developing world. However, there is no data available for rheumatic heart disease in the paediatric population of Sabah. This study collected data for acute rheumatic fever admissions among the paediatric population in Sabah over a period of 3 years. Methods: This is a retrospective cohort study. All records for admissions to paediatric wards in Sabah for acute rheumatic fever from January 2016 to December 2018 were collected. The patient records were then traced and required information were collected. Results: A total of 52 cases of acute rheumatic fever were admitted. It was observed that the incidence of acute rheumatic fever was 74.4 per 100,000 paediatric admissions. Patients from the West Coast Division made up most of the admissions (n = 24, 46.2%). Male patients (n = 35, 67.3%) of the indigenous Kadazan-Dusun ethnicity (n = 21, 40.4%) were most commonly encountered. The mean age at time of presentation was 9.58 years. Most cases admitted (n = 38, 73.1%) were categorised as Priority 1 (severe rheumatic heart disease). Conclusion: Most patients who were admitted had symptoms of heart failure and were diagnosed with severe rheumatic heart disease. Although this disease is preventable, the incidence in Sabah remains high. This study was limited as we only looked at patients who were admitted and we foresee the real incidence to be higher. Hence, there is an urgent need for a rheumatic heart disease registry in Malaysia to gather more data for prevention and early intervention.

show abstract

“…Thirdly, decreases in the proportion of MR and most of MS mortality can be explained by the decreasing prevalence of rheumatic heart disease in the United States, due to improved prevention. 30 , 31 , 32 The trend toward earlier surgical intervention has been supported by long‐term benefits in existing studies. 33 , 34 Additionally, the introduction of percutaneous repair of the mitral valve as an alternative treatment option for high‐risk surgical patients has afforded these patients a safer and equally effective strategy compared with the surgical approach.…”

Section: Discussionmentioning

confidence: 99%

Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020

Tan,

Yeo,

San

et al. 2024

JAHA

View full text Add to dashboard Cite

Background Percutaneous heart valve procedures have been increasingly performed over the past decade, yet real‐world mortality data on valvular heart disease (VHD) in the United States remain limited. Methods and Results We queried the Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research database among patients ≥15 years old from 1999 to 2020. VHD and its subtypes were listed as the underlying cause of death. We calculated age‐adjusted mortality rate (AAMR) per 100 000 individuals and determined overall trends by estimating the average annual percent change using the Joinpoint regression program. Subgroup analyses were performed based on demographic and geographic factors. In the 22‐year study, there were 446 096 VHD deaths, accounting for 0.80% of all‐cause mortality (56 014 102 people) and 2.38% of the total cardiovascular mortality (18 759 451 people). Aortic stenosis recorded the highest mortality of VHD‐related death in both male (109 529, 61.74%) and female (166 930, 62.13%) populations. The AAMR of VHD has declined from 8.4 (95% CI, 8.2–8.5) to 6.6 (95% CI, 6.5–6.7) per 100 000 population. Similar decreasing AAMR trends were also seen for the VHD subtypes. Men recorded higher AAMR for aortic stenosis and aortic regurgitation, whereas women had higher AAMR for mitral stenosis and mitral regurgitation. Mitral regurgitation had the highest change in average annual percent change in AAMR. Conclusions The mortality rate of VHD among the US population has declined over the past 2 decades. This highlights the likely efficacy of increasing surveillance and advancement in the management of VHD, resulting in improved outcomes.

show abstract

Rheumatic heart disease and socioeconomic development

Cited by 7 publications

References 9 publications

The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study

The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study

Acute rheumatic fever in the paediatric population: a descriptive study in the Malaysian state of Sabah

Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020

Contact Info

Product

Resources

About